|
TCERG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.380460E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.982600E-03 |
| Normal-vs-Stage2 |
3.096900E-03 |
| Normal-vs-Stage3 |
3.211400E-04 |
| Normal-vs-Stage4 |
3.178100E-02 |
| Stage1-vs-Stage2 |
3.873600E-01 |
| Stage1-vs-Stage3 |
1.915190E-01 |
| Stage1-vs-Stage4 |
9.351200E-01 |
| Stage2-vs-Stage3 |
9.343000E-01 |
| Stage2-vs-Stage4 |
4.733800E-01 |
| Stage3-vs-Stage4 |
3.363400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.637300E-04 |
| Normal-vs-AfricanAmerican |
9.770000E-02 |
| Normal-vs-Asian |
1.924600E-01 |
| Caucasian-vs-AfricanAmerican |
6.091800E-01 |
| Caucasian-vs-Asian |
1.575850E-01 |
| AfricanAmerican-vs-Asian |
5.923400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.257700E-02 |
| Normal-vs-Female |
3.601500E-04 |
| Male-vs-Female |
1.769610E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.248200E-02 |
| Normal-vs-Age(41-60Yrs) |
9.008100E-04 |
| Normal-vs-Age(61-80Yrs) |
2.617300E-03 |
| Normal-vs-Age(81-100Yrs) |
6.189700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.379400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.333600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.262600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.551800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.199800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.731400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.784100E-04 |
| Classical-VS-Follicular |
1.683970E-03 |
| Classical-VS-Other |
7.277000E-01 |
| Classical-VS-Normal |
4.001700E-02 |
| Tall-VS-Follicular |
4.976800E-01 |
| Tall-VS-Other |
2.277600E-01 |
| Tall-VS-Normal |
4.11089999999836E-05 |
| Follicular-VS-Other |
5.135800E-01 |
| Follicular-VS-Normal |
1.358320E-04 |
| Other-VS-Normal |
2.260400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.751810E-04 |
| Normal-vs-N1 |
4.261000E-01 |
| N0-vs-N1 |
2.973800E-02 |
|
|
